blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1924565

EP1924565 - DIAMINOPYRIMIDINES AS P2X3 AND P3X2/3 MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.07.2017
Database last updated on 12.11.2024
Most recent event   Tooltip11.10.2019Lapse of the patent in a contracting state
New state(s): CY		published on 13.11.2019  [2019/46]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2016/37]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Former [2008/22]For all designated states
F.HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / DILLON, Michael Patrick
275 Romain Street
San Francisco, California 94131 / US
02 / JAHANGIR, Alam
3655 Valley Ridge Lane
San Jose, California 95148 / US
03 / LUI, Alfred Sui-Ting
1026 Essex Avenue
Sunnyvale, California 94089 / US
04 / WILHELM, Robert Stephen
90 Hillview Avenue
Los Altos, California 94022 / US
 [2008/22]
Representative(s)Heiroth, Ulrike Hildegard
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2016/37]
Former [2008/22]Heiroth, Ulrike Hildegard
F. Hoffmann-La Roche AG Patent Department, Grenzacherstrasse 124
CH-4070 Basel / CH
Application number, filing date06778313.421.08.2006
[2008/22]
WO2006EP65525
Priority number, dateUS20050713243P01.09.2005         Original published format: US 713243 P
[2008/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007025900
Date:08.03.2007
Language:EN
[2007/10]
Type: A1 Application with search report 
No.:EP1924565
Date:28.05.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2007 takes the place of the publication of the European patent application.
[2008/22]
Type: B1 Patent specification 
No.:EP1924565
Date:14.09.2016
Language:EN
[2016/37]
Search report(s)International search report - published on:EP08.03.2007
ClassificationIPC:C07D239/48, C07D401/12, A61K31/506, A61P11/00, A61P13/00
[2008/22]
CPC:
C07D401/12 (EP,KR,US); C07D239/48 (EP,KR,US); A61K31/506 (KR);
A61P1/00 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P1/06 (EP); A61P1/12 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P13/08 (EP);
A61P13/10 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P29/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P39/02 (EP);
A61P43/00 (EP); A61P7/12 (EP); C07D471/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/37]
Former [2008/22]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:DIAMINOPYRIMIDINE ALS P2X3- UND P3X2/3-MODULATOREN[2008/22]
English:DIAMINOPYRIMIDINES AS P2X3 AND P3X2/3 MODULATORS[2008/22]
French:DIAMINOPYRIMIDINES EN TANT QUE MODULATEURS DE P2X3 ET P3X2/3[2008/22]
Entry into regional phase01.04.2008National basic fee paid 
01.04.2008Designation fee(s) paid 
01.04.2008Examination fee paid 
Examination procedure21.03.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.04.2008Examination requested  [2008/22]
26.05.2014Despatch of a communication from the examining division (Time limit: M04)
20.08.2014Reply to a communication from the examining division
14.04.2016Communication of intention to grant the patent
20.07.2016Fee for grant paid
20.07.2016Fee for publishing/printing paid
20.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.05.2014
Opposition(s)15.06.2017No opposition filed within time limit [2017/34]
Fees paidRenewal fee
27.03.2008Renewal fee patent year 03
07.08.2009Renewal fee patent year 04
06.08.2010Renewal fee patent year 05
08.08.2011Renewal fee patent year 06
08.08.2012Renewal fee patent year 07
07.08.2013Renewal fee patent year 08
07.08.2014Renewal fee patent year 09
07.08.2015Renewal fee patent year 10
05.08.2016Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.08.2006
AT14.09.2016
BE14.09.2016
CY14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
[2019/46]
Former [2019/31]HU21.08.2006
AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2018/18]AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/52]AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/34]AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/32]AT14.09.2016
BE14.09.2016
CZ14.09.2016
EE14.09.2016
FI14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
SE14.09.2016
SK14.09.2016
BG14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/13]FI14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
SE14.09.2016
GR15.12.2016
Former [2017/12]FI14.09.2016
LT14.09.2016
SE14.09.2016
GR15.12.2016
Former [2017/10]FI14.09.2016
LT14.09.2016
SE14.09.2016
Former [2017/07]LT14.09.2016
Cited inInternational search[A]WO0144213  (ASTRAZENECA AB [SE], et al) [A] 1,5-8 * abstract *;
 [A]WO02094767  (ABBOTT LAB [US]) [A] 1,5-8 * abstract *;
 [A]EP1310493  (PFIZER PROD INC [US]) [A] 1,5-8* claims 1,9-12 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.